RxDoctor Payments DataLook up a doctor →

James Rho, MD

Interventional Pain Medicine · Rancho Cucamonga, CANPI 1548323769

Payments from drug & device makers

$35,863in general payments, 2019–2025

Across 1,701 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
  • AbbVie$3K
  • Spinal Simplicity, LLC$3K
  • Pfizer$2K
  • Forte Bio-pharma LLC$2K
  • plus $19K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott123$4,605
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC177$2,861
AbbVie(2 entities)196$2,575
Spinal Simplicity, LLC10$2,563
Pfizer170$2,284
Forte Bio-pharma LLC90$1,812
Medtronic(2 entities)42$1,634
Amgen(2 entities)64$1,286
Collegium Pharmaceutical, Inc.109$1,243
Boston Scientific31$1,033
SPR Therapeutics, Inc6$669
Scilex Pharmaceuticals Inc.37$649
Lundbeck LLC29$630
Biohaven Pharmaceuticals, Inc.31$609
Teva Pharmaceuticals USA, Inc.31$554
Takeda Pharmaceuticals U.S.A., Inc.30$526
Nevro Corp.35$498
Biohaven Pharmaceutical Holding Company Ltd.36$491
Virtus Pharmaceuticals LLC22$463
Daiichi Sankyo Inc.32$453
Lilly USA, LLC21$435
Vertiflex, Inc.15$417
Indivior Inc.22$399
Saluda Medical Americas, Inc.5$386
Si-bone, Inc.5$377
Axsome Therapeutics, Inc.14$376
Zyla Life Sciences, Inc.53$346
Protega Pharmaceutials Inc18$325
Almatica Pharma LLC18$320
Eisai Inc.17$311
Arbor Pharmaceuticals, Inc.15$259
Foundation Fusion Solutions, LLC3$248
Globus Medical7$246
MML US, Inc.11$237
Nalu Medical, Inc.5$225
Upsher-smith Laboratories LLC9$202
Relievant Medsystems, Inc.2$192
Merck10$191
Kowa Pharmaceuticals America, Inc.9$178
Biodelivery Sciences International, Inc.8$175
Painteq LLC7$173
GRT US Holding, Inc.7$171
Redhill Biopharma Inc.9$157
Curonix LLC4$154
Phathom Pharmaceuticals, Inc.2$151
Supernus Pharmaceuticals, Inc.9$146
Trevena, Inc.19$134
Impel Pharmaceuticals Inc.6$131
Novartis9$124
Idorsia Pharmaceuticals US Inc6$106
Assertio Therapeutics, Inc.7$105
Johnson & Johnson1$103
MDD US Operations, LLC7$102
Azurity Pharmaceuticals, Inc.5$92
Averitas Pharma Inc.3$89
Shionogi Inc3$72
IBSA Pharma Inc.4$70
Valinor Pharma, LLC3$59
AstraZeneca3$59
Fidia Pharma USA Inc.2$53

How this compares

$35,863 in reported general payments places this provider in the 85th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$361,482
Medicare patients
317
Services billed
3,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Rancho Cucamonga

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →